1 Volume 2015, Article ID , 4 pages Case Report Cardiac Arrest following a Myocardial Infarction in a Child Treated with Methylphenidate Kim Munk, 1 Lise Gormsen, 2 Won Yong Kim, 1 and Niels Holmark Andersen 1 1 Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark 2 Department of Psychiatry, Aarhus University Hospital, Risskov Skovagervej 2, 8240 Risskov, Denmark Correspondence should be addressed to Kim Munk; Received 24 April 2015; Revised 16 June 2015; Accepted 16 June 2015 Academic Editor: Bibhuti Das Copyright 2015 Kim Munk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The use of psychostimulants labeled to treat attention deficit/hyperactivity disorder increases. Among side effects these drugs raise blood pressure and heart rate, and the safety has been scrutinised in recent years. Data from large epidemiological studies, including over a million person-years, did not report any cases of myocardial infarction in current users of methylphenidate, and the risk of serious adverse cardiac events was not found to be increased. We present a case with an 11-year-old child, treated with methylphenidate, who suffered cardiac arrest and was diagnosed with a remote myocardial infarction. This demonstrates that myocardial infarction can happen due to methylphenidate exposure in a cardiac healthy child, without cardiovascular risk factors. 1. Introduction The risk of cardiovascular events and sudden death related to attention deficit/hyperactivity disorder (ADHD) medications has been scrutinized in the recent years [1 5]. In adults, the initiation of methylphenidate has been foundtobeassociatedwithnearlyadoublingoftherate of sudden death or ventricular arrhythmia . However, in children and adolescents, large scale population studies have not found an increased cardiovascular risk in ADHD drug users . Although one study reported a high hazard ratio estimate for sudden death or ventricular arrhythmia with methylphenidate use, the results were nonsignificant . In children and adolescents, a low absolute number of cardiovascular events may explain why hazard ratios, even in large scale studies, come out nonsignificant. However, with the reported spreads in confidence intervals, one cannot rule outthepossibilityofanincreasebyasmuchasatriplingof the risk for serious cardiovascular events. Mechanisms behind cardiovascular disease and methylphenidate are not fully understood. Methylphenidate increases heart rate, increases blood pressure, and potentially causes arterial vasospasms, due to the increased levels of circulating catecholamines [5, 6]. All these factors could theoretically increase cardiovascular risk . There are no valid data to suggest that methylphenidate directly increases the corrected QT interval or induces arrhythmia [5, 7]. We present a case with a child treated with methylphenidate that suffered from cardiac arrest during exercise and was diagnosed with a remote myocardial infarction. 2. Case Presentation The patient is an 11-year-old boy with attention deficit/hyperactivity disorder and Tourette syndrome. Two years prior to the current incident he had been seen by a pediatric psychiatrist over a course of time and was finally treated with methylphenidate. He was slowly uptitrated to the maximum appropriate dose of 54 mg per day ( mg per day/body weight 50 kg), which had been ongoing ever since. Apparently, the child had been feeling well, but a week before his admission he felt dizzy and light headed after vigorous trampoline jumping. His mother noticed he had tachycardia but thought nothing of it. The incident only lasted afewminutesandafterwardshewaswell. Onthedayofadmission,thepatienthadbeeninconflict with one of his peers. To calm down, the patient was sent to the gym court, to exercise and play ball. After a few minutes
2 2 Figure 1: 12-lead electrocardiogram obtained on day five of the index admission. Abnormal Q-waves are seen in the left sided leads I, avl, and V4 V6. The QTc interval was normal at 395 msec (Fredericia correction). he left the court and fell down with cardiac arrest due to ventricular fibrillation. He was successfully resuscitated by school staff and the prehospital service. Upon hospital arrival the child was sedated and intubated. He was circulatory stable and he was treated with hypothermia for 24 hours. A urine toxicology screening only showed traces of the anesthetics used during the resuscitation and methylphenidate according to the prescribed dose. Both the initial ECG and the ECGs after hypothermia (Figure 1) showed Q-waves in leads I, AVL, and V4 6 and ventricular ectopic beats. The QT intervals were normal. The echocardiogram did not show any congenital defects but impaired left ventricular function due to regional wall motion abnormalities and thinning of the myocardial wall, consistent with a previous myocardial infarction in the circumflex artery area. There was only a minor increase in the troponin levels, which could be explained by the cardiac arrest, and the initial infection parameters were normal. A coronary computed tomography angiography scan showed normal coronary artery anatomy with a dominant left coronary artery and no signs of myocardial bridging. However, a subsequent cardiac magnetic resonance scan showed clear signs of an old myocardial infarction with delayed hyperenhancement and thinning of the lateral wall of the left ventricle, corresponding to the circumflex artery supply (Figure 2). To exclude paradox emboli, a transesophageal echocardiogram with bubble contrast was done. No atrial septal defects or mural thrombi were found. A full panel of blood coagulation tests did not reveal any coagulation disorder or hypercholesterolemia. Before discharge, a coronary angiogram was done, which confirmed the computed tomography angiography result but also excluded abnormal coronary spasm tendency by a methylergometrine test. The patient also had an invasive electrophysiology study, which showed normal atrioventricular conduction without accessory pathways and an easily inducible sustained ventricular tachycardia, deriving from the scar tissue in the left ventricle. Subsequently, an implantable cardioverter defibrillator was implanted, and the patient was put on a low dose of metoprolol succiante (25 mg), with a treatment plan to increase the dose at a later stage. The methylphenidate treatment was discontinued. A wide panel of genetic disorders related to tachyarrhythmia was examined, which all came out negative. Three weeks after discharge the child was on his own in a bouncy castle on a Friday evening. After 15 minutes of exercise, he shortly felt ill and sat down but recovered quickly without any recollection of chest pain or any other discomfort. The following Monday, the defibrillator telemetry showed that the pacemaker had defibrillated an episode of ventricular fibrillation (Figure 3). Following this episode, the metoprolol succiante dosage was increased to 100 mg o.d. over two weeks. 3. Discussion Acute myocardial infarction due to atherosclerotic plaque rupture is a leading cause of death and disability. However, in childhood and adolescence, myocardial infarction is extremely rare and other causes should be sought such as coronary artery anomalies, vasculitis, and coagulation defects. Due to the extremely rare occurrence in children, a myocardial infarction diagnosis may not be suspected and therefore overlooked. Likewise, myocardial infarction in children treated with methylphenidate is extremely rare. In two large epidemiological studies, including over half a million person-years of follow-up, of current users of attention deficit/hyperactivity disorder medications, not a single myocardial infarction was reported during treatment [1, 4]. The boy in this case report presented with cardiac arrest without any prior complaints about chest discomfort or shortness of breath. The only symptom was the short exertion induced tachycardia episode a week before the major event. Had this been presented for a physician, it is unlikely that it would have led to further diagnostic workup. In retrospect this episode was most likely caused by ventricular tachycardia. The large epidemiological studies on methylphenidate are based on reported diagnoses, among which this boy s myocardial infarction diagnosis probably would never have appeared. Instead, he suffered from cardiac arrest and would
3 3 (a) (b) Figure 2: Cardiac magnetic resonance (CMR) imaging showing short-axis views in diastole (a) by cine CMR and (b) by late gadolinium enhancement imaging. Arrows indicate myocardial wall thinning and late gadolinium enhancement in the circumflex artery area consistent with myocardial necrosis and scar formation. Figure 3: Reading from the implantable cardioverter defibrillator showing onset of ventricular fibrillation (arrow) at an average cycle length of 210 ms corresponding to a rate of 285 per minute. After the first shock (HV) delivered by the defibrillator, sinus rhythm is restored. have been classified as sudden cardiac death, had he not been resuscitated. When the boy was admitted, the first assumption was a primary arrhythmia. However the ECG clearly indicated regional myocardial necrosis and the echocardiogram showed thinning of the myocardial wall. The CMR scan clearly indicated that the myocardial infarction was of an older date (more than weeks) due to thinning of the myocardium and an adversely remodeled left ventricle. Currently there is no recommendation in Denmark or by the FDA to obtain ECG before and during methylphenidate treatment, explaining why there was no ECG prior to treatment. Theoretically, there may be more children with undiagnosed myocardial infarctions among methylphenidate users that are missed, if routine ECGs are not obtained on a regular basis. In the present case, the Q-waves in the ECG would have disclosed that the child had developed heart disease. Whether this would have altered the course is speculative. Obviously it may be questioned if the myocardial infarction actually developed prior to methylphenidate treatment and if it really was the cause. It is now two years since the index admission. The boys present clinical situation is quite concerning. Despite high dose ACE-inhibitors and betablockers his left ventricle has further adversely remodeled from an initial internal diastolic diameter of 5.4 cm to 7.2 cm on the latest echocardiography. His ejection fraction has deteriorated to 35%. He is in heart failure class II. He recently underwent two VT ablations due to long lasting tachycardia episodes and therapies from the ICD. Therefore it is unbelievable that this boy was started on methylphenidate after the huge myocardial infarct. He would have been in overt heart failure which would have been noticed. Children do not develop huge myocardial infarcts without a cause. This young boy has been very thoroughly examined. He did not suffer from hypertension or hypercholesterolemia, and there was no coronary artery anomaly, no myocardial bridging, no coagulation defects, no PFO, and no abnormal coronary spasm tendency to explain his myocardial infarct.
4 4 Furthermore, the dosage of methylphenidate was uptitrated correctly to an appropriate dosage and there was not any suspicion of abuse. The only thing that points out is the methylphenidate treatment, which FDA recognizes can cause heart attacks in adults. Randomized trials show that ADHD drugs reduce symptoms significantly, compared to placebo , and improve children s learning and academic achievement modestly . At present, the use of ADHD drugs is increasing. For this reason, even though registry studies do not show associations with cardiovascular events in children, it is important to closely monitor and report cardiovascular events to ensure that this treatment remains well controlled, efficient, and safe. In conclusion, myocardial infarction and sudden cardiac death are extremely rare among children during treatment with methylphenidate. However, the present case shows that myocardial infarction can happen due to methylphenidate exposure in a cardiac healthy child, without any other cardiovascular risk factor. Conflict of Interests The authors declare that there is no conflict of interests regarding the publication of this paper. References  W.O.Cooper,L.A.Habel,C.M.Soxetal., ADHDdrugsand serious cardiovascular events in children and young adults, The New England Medicine, vol.365,no.20,pp ,  S. E. Nissen, ADHD drugs and cardiovascular risk, The New England Medicine, vol.354,no.14,pp ,  H. Schelleman, W. B. Bilker, S. E. Kimmel et al., Methylphenidate and risk of serious cardiovascular events in adults, The American Psychiatry,vol.169,no.2,pp ,2012.  H. Schelleman, W. B. Bilker, B. L. Strom et al., Cardiovascular events and death in children exposed and unexposed to ADHD agents, Pediatrics, vol. 127, no. 6, pp ,  N. D. Volkow, G.-J. Wang, J. S. Fowler et al., Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma, Psychopharmacology,vol.166,no.3,pp ,2003.  A. N. Westover and E. A. Halm, Do prescription stimulants increase the risk of adverse cardiovascular events? A systematic review, BMC Cardiovascular Disorders,vol.12,article41,2012.  F. M. C. Besag and G. Stiefel, Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention-deficit hyperactivity disorder, Drug Safety, vol.33,no.10,pp ,2010.  M. Rösler, M. Casas, E. Konofal, and J. Buitelaar, Attention deficit hyperactivity disorder in adults, World Biological Psychiatry, vol. 11, no. 5, pp ,  V. Prasad, E. Brogan, C. Mulvaney, M. Grainge, W. Stanton, and K. Sayal, How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis, European Child and Adolescent Psychiatry, vol. 22, no. 4, pp , 2013.
5 MEDIATORS of INFLAMMATION The Scientific World Journal Gastroenterology Research and Practice Diabetes Research International Endocrinology Immunology Research Disease Markers Submit your manuscripts at BioMed Research International PPAR Research Obesity Ophthalmology Evidence-Based Complementary and Alternative Medicine Stem Cells International Oncology Parkinson s Disease Computational and Mathematical Methods in Medicine AIDS Behavioural Neurology Research and Treatment Oxidative Medicine and Cellular Longevity
What Are Arrhythmias? Many people have questions about what the word arrhythmia means, and arrhythmias can be a difficult subject to understand. The text below should give you a better understanding of
Instruction to doctor: This patient is insured with us against the happening of certain contingent events associated with his health. A claim has been submitted in connection with Heart attack / Cardiomyopathy
Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
Patient information factsheet Tachyarrhythmias (fast heart rhythms) The normal electrical system of the heart The heart has its own electrical conduction system. The conduction system sends signals throughout
GENERAL HEART DISEASE KNOW THE FACTS WHAT IS Heart disease is a broad term meaning any disease affecting the heart. It is commonly used to refer to coronary heart disease (CHD), a more specific term to
Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.
Additional Device Information 9529 Reveal XT Insertable Cardiac Monitor The Reveal XT Insertable Cardiac Monitor is an implantable patientactivated and automatically activated monitoring system that records
Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary
UW MEDICINE PATIENT EDUCATION Supraventricular Tachycardia (SVT) and Ablation Treating your abnormal heart rhythm This handout describes a type of abnormal heart rhythm called supraventricular tachycardia.
LIVING ASSURANCE / EPCC CLAIM DOCTOR S STATEMENT DOCTOR S STATEMENT FOR: HEART ATTACK * Please delete where appropriate For Official Use _ G E L S _ O A C S Name of Life Assured: NRIC/ Passport No.: of
THE FRAMINGHAM STUDY CRITERIA FOR EVENTS (SEQUENCE OF EVENTS FILE SOE ) 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation of coronary
Cardiology Cardiology Services Cardiology treats diseases that affect the heart and blood vessels. The human cardiovascular system pumps and circulates blood throughout the body, carrying oxygen and nutrients
ATTENDING PHYSICIAN S STATEMENT CRITICAL ILLNESS (HEART ATTACK) Name NRIC Number Policy Number Claim Number The abovenamed is insured with us against the happening of certain contingent events associated
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
A WorkLife4You Guide Heart Attack: What You Need to Know What is a Heart Attack? The heart works 24 hours a day, pumping oxygen and nutrient-rich blood to the body. Blood is supplied to the heart through
MHRA UK PUBLIC ASSESSMENT REPORT Atomoxetine: a review of the effects on heart rate and blood pressure May 2012 Plain-language summary 2 1. Introduction 5 2. Background 5 3. Methods 7 4. Results 9 4.1.
Arrhythmia Facts During a 24-hour period, about 20% of healthy adults are likely to have frequent or multiple types of premature ventricular heartbeats. Heart arrhythmias are very common and nearly everyone
Ophthalmology Volume 2015, Article ID 435606, 4 pages http://dx.doi.org/10.1155/2015/435606 Research Article Inconsistencies Exist in National Estimates of Eye Care Services Utilization in the United States
My life has taken a turn for the better. AF Answers A Patient Education Handbook on Electrophysiology My episodes of atrial fibrillation (AF) kept me from fully enjoying what I was accustomed to doing.
Glossary of Cardiology Terms Ablation The removal, isolation or destruction of cardiac tissue or conduction pathways involved in arrhythmias. Algorithm A set of precise rules or procedures programmed into
ATRIAL FIBRILLATION WHAT IS ATRIAL FIBRILLATION? Atrial fibrillation (AF) is a rapid and irregular rhythm disturbance of the upper chambers of the (atria) heart overriding the normal heart pacemaker. The
Catheter Ablation A Guided Approach for Treating Atrial Arrhythmias A P A T I E N T H A N D B O O K This brochure will provide an overview of atrial arrhythmias (heart rhythm problems affecting the upper
Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics Yen Tibayan, M.D. Division of Cardiovascular Medicine Case Presentation 69 y.o. woman calls 911 with the complaint of
SIGNAL AVERAGED ECG INTRODUCTION Signal-averaged electrocardiography (SAECG) is a special electrocardiographic technique, in which multiple electric signals from the heart are averaged to remove interference
Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,
YOUR TREATMENT TEAM CARDIOLOGIST What does a cardiologist do? A cardiologist is a doctor who specializes in caring for your heart and blood vessel health. To become a cardiologist, a doctor completes additional
IRREGULAR HEARTBEAT? Get your rhythm back. ABOUT ARRHYTHMIA If you ve been diagnosed with a cardiac arrhythmia, there has been a change from the normal sequence of electrical impulses in your heart, causing
January 2012 Purpose of the Project The human and financial costs of cardiovascular disease are enormous. Heart disease is the leading cause of death for men and women in the United States and was estimated
Acquired, Drug-Induced Long QT Syndrome A Guide for Patients and Health Care Providers Sudden Arrhythmia Death Syndromes (SADS) Foundation 508 E. South Temple, Suite 202 Salt Lake City, Utah 84102 800-STOP
PRESENTATION Vials of reteplase 10 units for reconstitution with 10ml water for injection. Vials of tenecteplase 10,000 units for reconstitution with 10ml water for injection, or 8,000 units for reconstitution
Requirements for Provision of Outreach Paediatric Cardiology Service Dr Shakeel A Qureshi, Consultant Paediatric Cardiologist, Evelina Children s Hospital, London, UK On behalf of British Congenital Cardiac
FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke
June 2013 Guide to Important Safety Information Using GILENYA In Patients with Relapsing Forms of Multiple Sclerosis R GILENYA (fingolimod) is a sphingosine 1-phosphate receptor (S1P) modulator indicated
Atrial Fibrillation Overview for Staff of Community Primary and Specialty Care Providers Atrial Fibrillation (AF or AFib) Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat
Living with Atrial Fibrillation U nderstanding Atrial Fibrillation An estimated 2.7 million Americans are living with atrial fibrillation (AF). That makes it the most common heart rhythm abnormality in
CRITICAL ILLNESS CLAIM FORM Critical Illness Claim Form - Instructions Policyholder (employer or plan administrator) Please complete the Policyholder s Statement and ensure that you answer each question
Academic Medicine Addictive Disorders & Their Treatment Advances in Anatomic Pathology Age & Ageing AIDS AIDS Patient Care & Stds AJN, American Journal of Nursing Alzheimer Disease & Associated Disorders
A PATIENT S GUIDE TO ELECTROPHYSIOLOGY STUDIES OF THE HEART The science of medicine. The compassion to heal. This teaching booklet is designed to introduce you to electrophysiology studies of the heart.
RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology
What are the surgical options to treat atrial fibrillation? New concepts for the surgical treatment of atrial fibrillation were introduced in recent years when the surgical device industry introduced different
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
Imaging of Muscular Dystrophy Cardiomyopathy Sadaf Bhutta Seattle Children s Hospital University of Washington NASCI 2015 San Diego, CA Financial: None Disclosures Off label use of Gadolinium in CMR Muscular
INFORMATION FOR PATIENTS AND FAMILIES A Patient s Guide to Living with Atrial Fibrillation 30 Bond Street, Toronto, ON M5B 1W8 Canada 416.864.6060 stmichaelshospital.com Form No. XXXXX Dev. XX/XXXX GOALS
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological
With/Without Contrast CT, MRI Studies should NOT be ordered simultaneously as dual studies (i.e., with and without contrast). Radiation exposure is doubled and both views are rarely necessary. The study
The Savvy PSC: Review of the 2014 Primary Stroke Certification Standards Wendi J. Roberts RN, BA, MS, TNS, CLNC Field Director, Surveyor Management and Development Division of Accreditation and Certification
Atrial Fibrillation What to Know About Atrial Fibrillation Understanding Afib Atrial fibrillation, or Afib, is a condition in which the heart beats irregularly speeding up or slowing down, or beating too
Novartis Gilenya FDO Program Clinical Protocol and Highlights from Prescribing Information (PI) Highlights from Prescribing Information - the link to the full text PI is as follows: http://www.pharma.us.novartis.com/product/pi/pdf/gilenya.pdf
References 1 Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
My follow-up questions: Global Headquarters Cardiac Rhythm One St. Jude Medical Drive Management Division St. Paul, Minnesota 55117 15900 Valley View Court USA Sylmar, California 91342 + 1 651 756 2000
J ohn Muir Cardiac Rhythm Center The John Muir Cardiac Rhythm Center, located at the John Muir Medical Center Walnut Creek has been carefully developed to diagnose and treat heart rhythm disorders or arrhythmias.
2012 ACCF/AHA/HRS Guidelines for Implantable Defibrillator and Cardiac Resynchronization for Cardiac Rhythm Abnormalities 1 Despite ICD and CRT being a Class I or IIa indication for treatment of patients,
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory
Chapter 8 Heart and Blood Vessels Three Types of Blood Vessels Transport Blood Arteries Carry blood away from the heart Transport blood under high pressure Capillaries Exchange solutes and water with cells
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Multiple Technology Appraisal Dual-chamber pacemakers for treating symptomatic bradycardia due to sick sinus syndrome or atrioventricular block, part review
Cardioversion for Atrial Fibrillation Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation When You Have Atrial Fibrillation You ve been told you have a heart condition called atrial
Marquette University e-publications@marquette Physician Assistant Studies Faculty Research and Publications Health Sciences, College of 8-12-2010 The P Wave: Indicator of Atrial Enlargement Patrick Loftis
HANDOUT STUDY UNIT 2 ARRHYTHMIA MANAGEMENT (BRADYCARDIA) Bradycardia is defined conservatively as a heart rate below 60 beats per minute, but symptomatic bradycardia generally entails rates below 50 beats
Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation
B r i g h a m a n d W o m e n s H o s p i t a l Cardiovascular Genetics Center Hypertrophic Cardiomyopathy Clinic The HCM Clinic at Brigham and Women s Hospital applies the latest scientific discoveries
Module 10 Heart Rhythm Problems The Heart Failure Society of America (HFSA) is a non-profit organization of health care professionals and researchers who are dedicated to enhancing quality and duration
The ALIVE Trial: Versus In Pre-Hospital Refractory Ventricular Fibrillation Evaluation Based on preliminary data of Dorian P et al as presented at the 22nd Annual Scientific Sessions of the North American
Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die
Treatments to Restore Normal Rhythm In many instances when AF causes significant symptoms or is negatively impacting a patient's health, the major goal of treatment is to restore normal rhythm and prevent
Heart Disorders Glossary ABG (Arterial Blood Gas) Test: A test that measures how much oxygen and carbon dioxide are in the blood. Anemia: A condition in which there are low levels of red blood cells in
6 Irregular Heartbeat (Arrhythmia) Dr. Rath s Vitamin program for Prevention and Adjunct Therapy Facts About Irregular Heartbeat How Patients With Irregular Heartbeat Benefit from Dr. Rath s Vitamin Program
Update on Small Animal Cardiopulmonary Resuscitation (CPR)- is anything new? DVM, DACVA Objective: Update on the new Small animal guidelines for CPR and a discussion of the 2012 Reassessment Campaign on
Cardiac Arrest VF/Pulseless VT Learning Station Checklist VF/VT 00 American Heart Association Adult Cardiac Arrest Shout for Help/Activate Emergency Response Epinephrine every - min Amiodarone Start CPR
Hypertrophic and Dilated Cardiomyopathy Rahul Deo, MD PHD Assistant Professor Division of Cardiology, UCSF Principal Investigator, CVRI Outline Definitions Epidemiology: the scope of the problem Genetics
BLOCK LETTERS PLEASE: CHESHIRE EAST COUNCIL DRIVER MEDICAL FULL NAME OF APPLICANT:.. DATE OF BIRTH.... ADDRESS:............. POST CODE... This certificate, which must be completed by a Registered Medical
This is a SAMPLE of the pretest you can access with your AHA PALS Course Manual at Heart.org/Eccstudent using your personal code that comes with your PALS Course Manual The American Heart Association strongly
Your consent to our cookies if you continue to use this website.